← Open Payments lookup

EMILY WALLACE: Open Payments

NPI 1326680331 · BELDING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$692 in 33 payments from 13 companies in 2025. Trend: 2023 $1,014 · 2024 $820 · 2025 $692

Food & beverage: $692
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$146
Novo Nordisk Inc5$109
Otsuka America Pharmaceutical, Inc.4$93
ABBVIE INC.4$78
Supernus Pharmaceuticals, Inc.3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
GlaxoSmithKline, LLC.2$37
Vanda Pharmaceuticals Inc.1$25
Axsome Therapeutics, Inc.1$24
Teva Pharmaceuticals USA, Inc.1$22

Products named: REXULTI, FARXIGA, AIRSUPRA, Qelbree, Ozempic, CAPLYTA, VRAYLAR, Wegovy.

Industry payments across MI — which companies pay providers there.